Holen Sie sich die Stockscreener-App
12.34
4.19%
-0.54
Handel nachbörslich:
12.06
-0.28
-2.27%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TLRY?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$12.88
Offen:
$13.5
24-Stunden-Volumen:
67.37M
Relative Volume:
6.31
Marktkapitalisierung:
$1.43B
Einnahmen:
$829.22M
Nettoeinkommen (Verlust:
$-248.96M
KGV:
-41.13
EPS:
-0.3
Netto-Cashflow:
$-92.10M
1W Leistung:
+46.38%
1M Leistung:
+19.81%
6M Leistung:
+221.94%
1J Leistung:
+6.38%
1-Tages-Spanne:
$12.09
$15.70
1-Wochen-Bereich:
$10.28
$15.70
52-Wochen-Spanne:
$3.507
$23.20
Tilray Brands Inc Stock (TLRY) Company Profile
Firmenname
Tilray Brands Inc
Sektor
Telefon
519.322.8800
Adresse
655 MADISON AVENUE, NEW YORK
Vergleichen Sie TLRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
12.34 | 1.49B | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
122.76 | 53.87B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.83 | 45.71B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.32 | 34.49B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
507.00 | 22.00B | 3.08B | 1.24B | 1.07B | 25.61 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-05 | Bestätigt | Alliance Global Partners | Neutral |
| 2022-11-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-07-29 | Herabstufung | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Eingeleitet | Barclays | Underweight |
| 2021-11-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Fortgesetzt | Cowen | Outperform |
| 2021-05-07 | Fortgesetzt | Jefferies | Buy |
| 2021-05-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-18 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-01 | Bestätigt | MKM Partners | Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-05-12 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-04-09 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-13 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-11-13 | Bestätigt | The Benchmark Company | Buy |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Bestätigt | Piper Jaffray | Overweight |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Eingeleitet | Consumer Edge Research | Overweight |
| 2019-06-06 | Eingeleitet | Stifel | Hold |
| 2019-06-05 | Eingeleitet | Oppenheimer | Perform |
| 2019-05-15 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Eingeleitet | Alliance Global Partners | Neutral |
Alle ansehen
Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten
Tilray Brands (NASDAQ:TLRY) Stock Price Down 4.2%Should You Sell? - MarketBeat
Stock Market Today, Dec. 18: Tilray Brands Jumps After Trump Order Spurs Cannabis Rescheduling - Nasdaq
Tilray Brands Unit to Accelerate US Medical Cannabis Operations After Regulatory Developments - marketscreener.com
Cloud lifts over cannabis companies’ future amid push to reclassify the drug - yourcentralvalley.com
Tilray and Canopy Growth Stocks Fall as Trump Reschedules Marijuana - Barron's
Tilray (TLRY) Expands U.S. Medical Cannabis Operations - GuruFocus
Tilray Medical, Division of Tilray Brands, Inc. Announces Formation of Tilray Medical USA, Inc - marketscreener.com
Tilray’s Meteoric Stock Rise: What’s Fueling it? - StocksToTrade
Tilray outlines U.S. medical cannabis strategy following rescheduling By Investing.com - Investing.com South Africa
Tilray outlines U.S. medical cannabis strategy following rescheduling - Investing.com
Tilray Up 2.6% As "Accelerates" U.S. Medical Cannabis Expansion After "Landmark" Federal Rescheduling - marketscreener.com
Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth - The Manila Times
What’s Behind Tilray’s 3.5X Surge? - Trefis
Tilray and Cannabis Stocks Soar Ahead of Expected Trump Executive Order on Marijuana - Barron's
Tilray Medical Announces Strategic Framework and Formation of Tilray Medical USA in Response to Federal Cannabis Rescheduling - Quiver Quantitative
How a global cannabis provider is gearing up for a new era in U.S. care - Stock Titan
Tilray Brands (TSE:TLRY) Shares Up 13.1%Here's Why - MarketBeat
Stocks making big moves yesterday: Broadcom, Olaplex, Paycom, Tilray, and Workiva - The Globe and Mail
Cannabis Stocks To Watch NowDecember 18th - MarketBeat
Is Tilray Brands Inc. stock positioned well for digital economyEarnings Overview Summary & Growth Focused Entry Reports - Улправда
Tilray Brands, Inc. (TLRY): A Bear Case Theory - Insider Monkey
Tilray Shares Navigate a Storm of Speculation - AD HOC NEWS
Small Cap Stocks To Watch NowDecember 14th - MarketBeat
Tilray Brands (TLRY) Stock in December 2025: Reverse Split, 90% Rally and What the Latest Forecasts Really Say - ts2.tech
Best Cannabis Stocks Worth WatchingDecember 14th - MarketBeat
Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026 - Yahoo! Finance Canada
Tilray Brands (NASDAQ:TLRY) Stock Price Down 7.6%Time to Sell? - MarketBeat
Why Tilray (TLRY) Shares Are Falling Today - Finviz
Tilray Brands (TLRY) Stock News Today: Cannabis Rally Cools as Trump Schedule III Speculation Fuels Volatility - ts2.tech
Promising Cannabis Stocks To Follow TodayDecember 17th - MarketBeat
High Hopes: Pot Stocks Blaze As Trump Eyes Rescheduling - Benzinga
Cannabis Stocks Can't Stop Rallying – Tilray Rockets Another 27% - MoneyMorning.com
Pot stocks rally as Trump expected to sign executive order on rescheduling - Seeking Alpha
Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go? - Fast Company
TLRY Stock Gained Over 70% In 5 Days, Retail Optimism Spikes Ahead Of Trump's Marijuana Order - Asianet Newsable
Tilray Brands (TLRY) Stock: Explodes 27% on Massive Volume as Cannabis Optimism Builds - Blockonomi
Tilray Brands Stock (TLRY) Update — What Investors Need to Know - TipRanks
Tilray Brands (TLRY) Stock Soars 27% on Cannabis Reclassification Talk - CoinCentral
Tilray Brands (TLRY) Stock News Today: Trump Cannabis Rescheduling Reports Fuel Volatility, Fresh Forecasts and Key Levels (Dec. 17, 2025) - ts2.tech
Tilray Brands Inc. (TLRY.TO): A Deep Dive into Canada’s Top Gainer in Healthcare - Meyka
Tilray Stock On Track For Near 2-Month High As 'Weednesday' Buzz Builds Around Trump Cannabis Order — Retail Eyes Massive Upside - Stocktwits
Tilray Brands, Pfizer, Netflix, Lennar Corp. And Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Why Tilray stock soared 27.5% today - MSN
Why Tilray Stock Soared 27.5% Today - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Trading Up 27.5%Still a Buy? - MarketBeat
Stock Market Today, Dec. 16: Tilray Brands Surges 27.5% After Trump Signals Possible Marijuana Reclassification - Yahoo Finance
Option Traders Are Pricing a Nearly 22% Move in Tilray Stock Before the End of 2025. Should You Buy, Sell, or Hold TLRY Here? - Barchart.com
Tilray Stock Soars Amid Potential Policy Changes - StocksToTrade
Is Tilray Stock Headed To New Highs? What You Need To KnowTilray Brands (NASDAQ:TLRY) - Benzinga
Trump’s Giving Cannabis Stocks a Lift—and the Optimism May Be Justified - Barron's
Promising Cannabis Stocks Worth WatchingDecember 16th - MarketBeat
Finanzdaten der Tilray Brands Inc-Aktie (TLRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
12.55%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):